ecancer

Immune reconstitution and preliminary safety analysis of somatic gene therapy

Dr Sung-Yun Pai - Harvard Medical School, Boston, USA

7 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France

3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands

3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

Elderly population needs new definition to inform treatment decisions

Dr Reinhard Stauder, Prof Mario Boccadoro

27 Nov 2013

Expert care is needed for elderly haematology patients

Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg

27 Nov 2013

Aiding treatment of HIV and cancer with aspirin

Dr Andrew Freedman - National Cancer Institute, Bethesda, USA

27 Nov 2013

ISIS 2 study: Use of aspirin to prevent cardiovascular problems

Dr Conrad Keating - University of Oxford, UK

27 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

14 Nov 2013

The future of CLL treatment: balancing efficacy, safety and cost

Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA

14 Nov 2013

Making sense of the expanding armoury of treatment options for the less fit CLL patient

Dr Valentin Goede - Uniklinik Köln, Cologne, Germany

14 Nov 2013

More from ecancer